Julian A. Symons Aligos Therapeutics, Inc. (ALGS) insider trading activity
Julian A. Symons is of Aligos Therapeutics, Inc.. Currently has a direct ownership of 394,064 shares of ALGS, which is worth approximately $3.7 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 18,517 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
394K
0%
3M change
0%
12M change
Total Value Held
$3.7 Million
JAS
Julian A. Symons
South San Francisco, CA